Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 92765596

  Document Type - Tender Notices

Description - Description: Scope of procurementBrief descriptionThe subject of this publication is the conclusion of contracts pursuant to Section 130a Para. 8 SGB V for several active ingredients as part of a so-called open house procedure: Under the specificatio n of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the conclusion of discount contracts pursuant to Section 130a Para. 8 SGB V for the following active ingredients:Apremilast (L04AA32)Benralizumab (R03DX10)Bosutinib (L01EA04)Brimonidine & Brinzolamide (S01EC24)Calcium carbonate & colecalciferol (A12AX01)Certolizumab (L04AB05)Dexame

Gt Ref Id - 92765596

Deadline - Sep 01, 2026